Although long-term oral anticoagulation therapy can significantly reduce thromboembolic complications among patients with atrial fibrillation, adherence to therapy can be challenging. Researchers evaluated...
It is the first sodium-glucose co-transporter 2 inhibitor to be approved to treat adults with New York Heart Association’s functional class II-IV heart failure with reduced ejection fraction.
Because the safety of individual DOACs relative to warfarin for specific bleeding outcomes in patients with atrial fibrillation is unclear, the researchers compared the safety of 3 DOACs with the safety of...
In a new post-hoc analysis, researchers investigated the risks and benefits of aspirin use among patients with atrial fibrillation with recent acute coronary syndrome or percutaneous coronary intervention....
It is uncertain how body mass index impacts cardiovascular outcomes among patients receiving intensive low-density lipoprotein cholesterol–lowering therapy. New research has shed light on the association. ...
The researchers sought to better understand the prognostic role of high-sensitivity cardiac troponin I among patients with newly detected atrial fibrillation. Here is what they found.
The association between statins and diabetes mellitus is controversial. To better understand the connection, investigators of the KP CHAMP study analyzed the risk of incident diabetes mellitus among...
Authors of a new study analyzed data on more than 8 million patients to better understand the association between blood pressure variability and atrial fibrillation risk. Do you think hypertension affected...
How does preeclampsia affect women’s 15-year risk of myocardial infarction, stroke, cardiovascular mortality, and all-cause mortality? Researchers recently investigated, and their findings might surprise...
Based on its oral bioavailability and half-life, torsemide may appear to be a more efficient diuretic than furosemide, but authors of a new study wanted to shed more light on the medications’ clinical...
